{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:24:04Z","timestamp":1791343444192,"version":"4.3.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/nm.4336","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T15:01:06Z","timestamp":1494860466000},"page":"692-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":406,"title":["Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-8594","authenticated-orcid":false,"given":"Alice","family":"Giustacchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supat","family":"Thongjuea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Barkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter S","family":"Woll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J","family":"Povinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A G","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggiero","family":"Norfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Rodriguez-Meira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Ashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3931-0914","authenticated-orcid":false,"given":"Paresh","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Segerstolpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2512-9199","authenticated-orcid":false,"given":"Hong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Olsson-Str\u00f6mberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu","family":"Mustjoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6473-1740","authenticated-orcid":false,"given":"Rickard","family":"Sandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten Eirik W","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8522-1002","authenticated-orcid":false,"given":"Adam J","family":"Mead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"BFnm4336_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","volume":"27","author":"N McGranahan","year":"2015","unstructured":"McGranahan, N. & Swanton, C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 27, 15\u201326 (2015).","journal-title":"Cancer Cell"},{"key":"BFnm4336_CR2","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMoa0912228","volume":"363","author":"R Tehranchi","year":"2010","unstructured":"Tehranchi, R. et al. Persistent malignant stem cells in del(5q) myelodysplasia in remission. N. Engl. J. Med. 363, 1025\u20131037 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4336_CR3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ccr.2012.03.003","volume":"21","author":"JA Magee","year":"2012","unstructured":"Magee, J.A., Piskounova, E. & Morrison, S.J. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283\u2013296 (2012).","journal-title":"Cancer Cell"},{"key":"BFnm4336_CR4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ccr.2014.03.036","volume":"25","author":"PS Woll","year":"2014","unstructured":"Woll, P.S. et al. Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. Cancer Cell 25, 794\u2013808 (2014).","journal-title":"Cancer Cell"},{"key":"BFnm4336_CR5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.exphem.2013.07.001","volume":"41","author":"I Sloma","year":"2013","unstructured":"Sloma, I. et al. Genotypic and functional diversity of phenotypically defined primitive hematopoietic cells in patients with chronic myeloid leukemia. Exp. Hematol. 41, 837\u2013847 (2013).","journal-title":"Exp. Hematol."},{"key":"BFnm4336_CR6","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/leu.2013.19","volume":"27","author":"S Mustjoki","year":"2013","unstructured":"Mustjoki, S. et al. Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients. Leukemia 27, 1520\u20131526 (2013).","journal-title":"Leukemia"},{"key":"BFnm4336_CR7","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm.3915","volume":"21","author":"AA Alizadeh","year":"2015","unstructured":"Alizadeh, A.A. et al. Toward understanding and exploiting tumor heterogeneity. Nat. Med. 21, 846\u2013853 (2015).","journal-title":"Nat. Med."},{"key":"BFnm4336_CR8","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1093\/hmg\/ddv235","volume":"24","author":"QF Wills","year":"2015","unstructured":"Wills, Q.F. & Mead, A.J. Application of single-cell genomics in cancer: promise and challenges. Hum. Mol. Genet. 24, R74\u2013R84 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm4336_CR9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.molcel.2015.05.005","volume":"58","author":"Y Wang","year":"2015","unstructured":"Wang, Y. & Navin, N.E. Advances and applications of single-cell sequencing technologies. Mol. Cell 58, 598\u2013609 (2015).","journal-title":"Mol. Cell"},{"key":"BFnm4336_CR10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A.P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"BFnm4336_CR11","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.aab0917","volume":"349","author":"DT Miyamoto","year":"2015","unstructured":"Miyamoto, D.T. et al. RNA-seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science 349, 1351\u20131356 (2015).","journal-title":"Science"},{"key":"BFnm4336_CR12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"BFnm4336_CR13","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","volume":"2","author":"BJ Druker","year":"1996","unstructured":"Druker, B.J. et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med. 2, 561\u2013566 (1996).","journal-title":"Nat. Med."},{"key":"BFnm4336_CR14","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM200104053441409","volume":"344","author":"JM Goldman","year":"2001","unstructured":"Goldman, J.M. & Melo, J.V. Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1084\u20131086 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4336_CR15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1056\/NEJMe1700833","volume":"376","author":"DL Longo","year":"2017","unstructured":"Longo, D.L. Imatinib changed everything. N. Engl. J. Med. 376, 982\u2013983 (2017).","journal-title":"N. Engl. J. Med."},{"key":"BFnm4336_CR16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.hoc.2011.09.001","volume":"25","author":"P Gallipoli","year":"2011","unstructured":"Gallipoli, P., Abraham, S.A. & Holyoake, T.L. Hurdles toward a cure for CML: the CML stem cell. Hematol.\/oncol. Clinics North Am. 25, 951\u2013966 (2011).","journal-title":"Hematol.\/oncol. Clinics North Am."},{"key":"BFnm4336_CR17","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1182\/blood-2010-12-327437","volume":"118","author":"S Chu","year":"2011","unstructured":"Chu, S. et al. Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment. Blood 118, 5565\u20135572 (2011).","journal-title":"Blood"},{"key":"BFnm4336_CR18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","volume":"11","author":"FX Mahon","year":"2010","unstructured":"Mahon, F.X. et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, ulticenter Stop Imatinib (STIM) trial. Lancet Oncol. 11, 1029\u20131035 (2010).","journal-title":"Lancet Oncol."},{"key":"BFnm4336_CR19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","volume":"13","author":"K Schepers","year":"2013","unstructured":"Schepers, K. et al. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13, 285\u2013299 (2013).","journal-title":"Cell Stem Cell"},{"key":"BFnm4336_CR20","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1164390","volume":"322","author":"A Colmone","year":"2008","unstructured":"Colmone, A. et al. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 322, 1861\u20131865 (2008).","journal-title":"Science"},{"key":"BFnm4336_CR21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.stem.2015.02.014","volume":"16","author":"K Schepers","year":"2015","unstructured":"Schepers, K., Campbell, T.B. & Passegu\u00e9, E. Normal and leukemic stem cell niches: insights and therapeutic opportunities. Cell Stem Cell 16, 254\u2013267 (2015).","journal-title":"Cell Stem Cell"},{"key":"BFnm4336_CR22","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ccell.2015.04.004","volume":"27","author":"RS Welner","year":"2015","unstructured":"Welner, R.S. et al. Treatment of chronic myelogenous leukemia by blocking cytokine alterations found in normal stem and progenitor cells. Cancer Cell 27, 671\u2013681 (2015).","journal-title":"Cancer Cell"},{"key":"BFnm4336_CR23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","volume":"20","author":"D Reynaud","year":"2011","unstructured":"Reynaud, D. et al. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell 20, 661\u2013673 (2011).","journal-title":"Cancer Cell"},{"key":"BFnm4336_CR24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nprot.2014.006","volume":"9","author":"S Picelli","year":"2014","unstructured":"Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171\u2013181 (2014).","journal-title":"Nat. Protoc."},{"key":"BFnm4336_CR25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.stem.2015.04.004","volume":"16","author":"NK Wilson","year":"2015","unstructured":"Wilson, N.K. et al. Combined single-cell functional and gene expression analysis resolves heterogeneity within stem cell populations. Cell Stem Cell 16, 712\u2013724 (2015).","journal-title":"Cell Stem Cell"},{"key":"BFnm4336_CR26","first-page":"858","volume":"9","author":"SQ Wu","year":"1995","unstructured":"Wu, S.Q. et al. Extensive amplification of bcr\/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562. Leukemia 9, 858\u2013862 (1995).","journal-title":"Leukemia"},{"key":"BFnm4336_CR27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nmeth.2694","volume":"11","author":"AR Wu","year":"2014","unstructured":"Wu, A.R. et al. Quantitative assessment of single-cell RNA-sequencing methods. Nat. Methods 11, 41\u201346 (2014).","journal-title":"Nat. Methods"},{"key":"BFnm4336_CR28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nprot.2012.022","volume":"7","author":"S Islam","year":"2012","unstructured":"Islam, S. et al. Highly multiplexed and strand-specific single-cell RNA 5\u2032 end sequencing. Nat. Protoc. 7, 813\u2013828 (2012).","journal-title":"Nat. Protoc."},{"key":"BFnm4336_CR29","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/leu.2008.392","volume":"23","author":"I Bruns","year":"2009","unstructured":"Bruns, I. et al. The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence. Leukemia 23, 892\u2013899 (2009).","journal-title":"Leukemia"},{"key":"BFnm4336_CR30","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood.V122.21.1477.1477","volume":"122","author":"K Miyawaki","year":"2013","unstructured":"Miyawaki, K. et al. The expansion of CML clones initiates at the CMP stage, and is associated with the down-regulation of IRF8 and GFI1. Blood 122, 1477 (2013).","journal-title":"Blood"},{"key":"BFnm4336_CR31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fimmu.2013.00204","volume":"4","author":"LG Schuettpelz","year":"2013","unstructured":"Schuettpelz, L.G. & Link, D.C. Regulation of hematopoietic stem cell activity by inflammation. Front. Immunol. 4, 204 (2013).","journal-title":"Front. Immunol."},{"key":"BFnm4336_CR32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri3062","volume":"11","author":"KY King","year":"2011","unstructured":"King, K.Y. & Goodell, M.A. Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat. Rev. Immunol. 11, 685\u2013692 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm4336_CR33","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1084\/jem.20110752","volume":"208","author":"CJ Pronk","year":"2011","unstructured":"Pronk, C.J., Veiby, O.P., Bryder, D. & Jacobsen, S.E. Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors. J. Exp. Med. 208, 1563\u20131570 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnm4336_CR34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1182\/blood.V75.1.96.96","volume":"75","author":"JD Cashman","year":"1990","unstructured":"Cashman, J.D., Eaves, A.C., Raines, E.W., Ross, R. & Eaves, C.J. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta. Blood 75, 96\u2013101 (1990).","journal-title":"Blood"},{"key":"BFnm4336_CR35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani, M. et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood 122, 872\u2013884 (2013).","journal-title":"Blood"},{"key":"BFnm4336_CR36","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm.2819","volume":"18","author":"A Kentsis","year":"2012","unstructured":"Kentsis, A. et al. Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia. Nat. Med. 18, 1118\u20131122 (2012).","journal-title":"Nat. Med."},{"key":"BFnm4336_CR37","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1242\/dev.086157","volume":"140","author":"JX Liu","year":"2013","unstructured":"Liu, J.X. et al. Eaf1 and Eaf2 negatively regulate canonical Wnt\/\u03b2-catenin signaling. Development 140, 1067\u20131078 (2013).","journal-title":"Development"},{"key":"BFnm4336_CR38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ccr.2010.12.012","volume":"19","author":"N Goardon","year":"2011","unstructured":"Goardon, N. et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 19, 138\u2013152 (2011).","journal-title":"Cancer Cell"},{"key":"BFnm4336_CR39","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/asheducation-2008.1.436","volume":"2008","author":"CH Jamieson","year":"2008","unstructured":"Jamieson, C.H. Chronic myeloid leukemia stem cells. Hematology Am. Soc. Hematol. Educ. Program. 2008, 436\u2013442 (2008).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program."},{"key":"BFnm4336_CR40","first-page":"4787","volume":"7","author":"K Zhao","year":"2014","unstructured":"Zhao, K. et al. IL1RAP as a surface marker for leukemia stem cells is related to clinical phase of chronic myeloid leukemia patients. Int. J. Clin. Exp. Med. 7, 4787\u20134798 (2014).","journal-title":"Int. J. Clin. Exp. Med."},{"key":"BFnm4336_CR41","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","volume":"123","author":"H Herrmann","year":"2014","unstructured":"Herrmann, H. et al. Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. Blood 123, 3951\u20133962 (2014).","journal-title":"Blood"},{"key":"BFnm4336_CR42","doi-asserted-by":"crossref","first-page":"715","DOI":"10.18632\/oncotarget.990","volume":"4","author":"JM Gerber","year":"2013","unstructured":"Gerber, J.M. et al. Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations. Oncotarget 4, 715\u2013728 (2013).","journal-title":"Oncotarget"},{"key":"BFnm4336_CR43","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/leu.2016.34","volume":"30","author":"E Nievergall","year":"2016","unstructured":"Nievergall, E. et al. TGF-\u03b1 and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy. Leukemia 30, 1263\u20131272 (2016).","journal-title":"Leukemia"},{"key":"BFnm4336_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri2726","volume":"10","author":"A Trumpp","year":"2010","unstructured":"Trumpp, A., Essers, M. & Wilson, A. Awakening dormant haematopoietic stem cells. Nat. Rev. Immunol. 10, 201\u2013209 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnm4336_CR45","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.2304","volume":"17","author":"H Clevers","year":"2011","unstructured":"Clevers, H. The cancer stem cell: premises, promises and challenges. Nat. Med. 17, 313\u2013319 (2011).","journal-title":"Nat. Med."},{"key":"BFnm4336_CR46","doi-asserted-by":"publisher","unstructured":"Warfvinge, R. et al. Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML. Blood \n                    http:\/\/dx.doi.org\/10.1182\/blood-2016-07-728873\n                    \n                   (2017).","DOI":"10.1182\/blood-2016-07-728873"},{"key":"BFnm4336_CR47","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1126\/science.1259037","volume":"346","author":"MR Mansour","year":"2014","unstructured":"Mansour, M.R. et al. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 346, 1373\u20131377 (2014).","journal-title":"Science"},{"key":"BFnm4336_CR48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bjh.13966","volume":"173","author":"S Soverini","year":"2016","unstructured":"Soverini, S., De Benedittis, C., Mancini, M. & Martinelli, G. Present and future of molecular monitoring in chronic myeloid leukaemia. Br. J. Haematol. 173, 337\u2013349 (2016).","journal-title":"Br. J. Haematol."},{"key":"BFnm4336_CR49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12495","volume":"502","author":"A Sanjuan-Pla","year":"2013","unstructured":"Sanjuan-Pla, A. et al. Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy. Nature 502, 232\u2013236 (2013).","journal-title":"Nature"},{"key":"BFnm4336_CR50","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.devcel.2010.02.012","volume":"18","author":"G Guo","year":"2010","unstructured":"Guo, G. et al. Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst. Dev. Cell 18, 675\u2013685 (2010).","journal-title":"Dev. Cell"},{"key":"BFnm4336_CR51","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).","journal-title":"Genome Biol."},{"key":"BFnm4336_CR52","doi-asserted-by":"crossref","first-page":"e1000598","DOI":"10.1371\/journal.pcbi.1000598","volume":"5","author":"D Ramsk\u00f6ld","year":"2009","unstructured":"Ramsk\u00f6ld, D., Wang, E.T., Burge, C.B. & Sandberg, R. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput. Biol. 5, e1000598 (2009).","journal-title":"PLoS Comput. Biol."},{"key":"BFnm4336_CR53","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/nbt.2967","volume":"32","author":"AA Pollen","year":"2014","unstructured":"Pollen, A.A. et al. Low-coverage single-cell mRNA sequencing reveals cellular heterogeneity and activated signaling pathways in developing cerebral cortex. Nat. Biotechnol. 32, 1053\u20131058 (2014).","journal-title":"Nat. Biotechnol."},{"key":"BFnm4336_CR54","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nbt.3039","volume":"32","author":"AM Streets","year":"2014","unstructured":"Streets, A.M. & Huang, Y. How deep is enough in single-cell RNA-seq? Nat. Biotechnol. 32, 1005\u20131006 (2014).","journal-title":"Nat. Biotechnol."},{"key":"BFnm4336_CR55","unstructured":"Iglewicz, B. & Hoaglin, D.C. How to detect and handle outliers (ASQC Quality Press, Milwaukee, Wis., 1993)."},{"key":"BFnm4336_CR56","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1126\/science.aaa1934","volume":"347","author":"A Zeisel","year":"2015","unstructured":"Zeisel, A. et al. Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science 347, 1138\u20131142 (2015).","journal-title":"Science"},{"key":"BFnm4336_CR57","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1186\/s13059-014-0525-9","volume":"15","author":"A Saadatpour","year":"2014","unstructured":"Saadatpour, A., Guo, G., Orkin, S.H. & Yuan, G.C. Characterizing heterogeneity in leukemic cells using single-cell gene expression analysis. Genome Biol. 15, 525 (2014).","journal-title":"Genome Biol."},{"key":"BFnm4336_CR58","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M.E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"BFnm4336_CR59","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm4336_CR60","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M.I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"BFnm4336_CR61","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1182\/blood-2013-03-490425","volume":"122","author":"D Beck","year":"2013","unstructured":"Beck, D. et al. Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes. Blood 122, e12\u2013e22 (2013).","journal-title":"Blood"},{"key":"BFnm4336_CR62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"BFnm4336_CR63","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).","journal-title":"Genome Biol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.4336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4336","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nm.4336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nm.4336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:01:43Z","timestamp":1684450903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.4336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFnm4336"],"URL":"https:\/\/doi.org\/10.1038\/nm.4336","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]},"assertion":[{"value":"14 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.J.M. has received honoraria and research funding from Novartis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}